Hjem › Myeloproliferative neoplasmer › Nevada › Las Vegas
Kliniske studier for Myeloproliferative neoplasmer i Las Vegas, NV
3 studier for Myeloproliferative neoplasmer søker deltakere på steder i og rundt Las Vegas (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekruttererFase 2
- OptumCare Cancer Care at Charleston, Las Vegas
- OptumCare Cancer Care at Fort Apache, Las Vegas
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekruttererFase 2
- OptumCare Cancer Care at Charleston, Las Vegas
- OptumCare Cancer Care at Fort Apache, Las Vegas
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- University Medical Center of Southern Nevada, Las Vegas
- Sunrise Hospital and Medical Center, Las Vegas
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
- og 2 flere
Myeloproliferative neoplasmer-studier i andre byer
- Houston, TX16 studier
- New York City, NY15 studier
- Boston, MA14 studier
- Milwaukee, WI10 studier
- Miami, FL10 studier
- Durham, NC9 studier
- Baldwin Park, CA9 studier
- Seattle, WA9 studier
- Chicago, IL9 studier
- Portland, OR8 studier
- Cleveland, OH8 studier
- Atlanta, GA8 studier
Andre studier i Las Vegas
- Fedme27 studier
- Overvekt23 studier
- Type 2-diabetes18 studier
- Ikke-småcellet lungekreft13 studier
- Major depresjon13 studier
- Brystkreft10 studier
- Alzheimers sykdom8 studier
- Akut myelogen leukemi8 studier
- Prostatakreft8 studier
- Kreft (alle typer)8 studier
- Schizofreni7 studier
- Aterosklerose7 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.